Niagen Bioscience (NAGE) Invested Capital (2011 - 2020)

Niagen Bioscience (NAGE) has 6 years of Invested Capital data on file, last reported at $161000.0 in Q2 2020.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $161000.0 in Q2 2020; TTM through Mar 2021 was $161000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $871000.0, changed 0.0% from the prior year.
• Invested Capital for Q2 2020 stood at $161000.0, down from $871000.0 in the prior quarter.
• Over the last five years, Invested Capital for NAGE reached as high as $1.5 million in Q1 2016 and fell as low as $161000.0 in Q2 2020.
• Historically, Invested Capital has averaged $755115.6 across 4 years, with a median of $871000.0 in 2017.
• Across the five-year window, Invested Capital plunged 77.5% in 2016 and soared 153.2% in 2017, its largest moves.
• Year by year, Invested Capital stood at $344000.0 in 2016, then surged by 153.2% to $871000.0 in 2017, then changed by 0.0% to $871000.0 in 2018, then plunged by 81.52% to $161000.0 in 2020.
• Per Business Quant data, the three most recent Invested Capital figures were $161000.0 in Q2 2020, $871000.0 in Q4 2018, and $871000.0 in Q4 2017.